These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Drug safety evaluation of rotigotine. Sprenger FS; Seppi K; Poewe W Expert Opin Drug Saf; 2012 May; 11(3):503-12. PubMed ID: 22468676 [TBL] [Abstract][Full Text] [Related]
9. Rotigotine and restless legs syndrome: new indication. The worst dopamine agonist. Just as unsatisfactory; defective design. Prescrire Int; 2009 Oct; 18(103):197. PubMed ID: 19882782 [No Abstract] [Full Text] [Related]
10. Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease. Chen JJ; Swope DM; Dashtipour K; Lyons KE Pharmacotherapy; 2009 Dec; 29(12):1452-67. PubMed ID: 19947805 [TBL] [Abstract][Full Text] [Related]
11. Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome. Nardone R; Ausserer H; Bratti A; Covi M; Lochner P; Marth R; Tezzon F Acta Neurol Scand; 2006 Oct; 114(4):244-9. PubMed ID: 16942543 [TBL] [Abstract][Full Text] [Related]
12. A controlled trial of rotigotine monotherapy in early Parkinson's disease. Parkinson Study Group Arch Neurol; 2003 Dec; 60(12):1721-8. PubMed ID: 14676046 [TBL] [Abstract][Full Text] [Related]
13. Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease. Chatsis V Issues Emerg Health Technol; 2008 Feb; (112):1-6. PubMed ID: 18354859 [No Abstract] [Full Text] [Related]
14. [Continued Use of Rotigotine Transdermal Patches for Parkinson Disease]. Yasutaka Y; Fujioka S; Shibaguchi H; Imakyure O; Washiyama A; Tsuboi Y; Futagami K Brain Nerve; 2016 Jun; 68(6):655-60. PubMed ID: 27279164 [TBL] [Abstract][Full Text] [Related]
15. Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overview. Zesiewicz TA; Martinez-Martin P Expert Rev Neurother; 2013 Dec; 13(12):1329-42. PubMed ID: 24236902 [TBL] [Abstract][Full Text] [Related]
16. Rotigotine transdermal system for the treatment of Parkinson's disease. Pham DQ; Nogid A Clin Ther; 2008 May; 30(5):813-24. PubMed ID: 18555929 [TBL] [Abstract][Full Text] [Related]
17. Transdermal rotigotine (Neupro) for Parkinson's disease. Med Lett Drugs Ther; 2007 Aug; 49(1268):69-70. PubMed ID: 17712291 [No Abstract] [Full Text] [Related]
18. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome. Splinter MY Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296 [TBL] [Abstract][Full Text] [Related]